What is Ecto Development?
Headquartered in Missouri, Ecto Development Corporation operates as a critical nexus for animal health product development, chemical analysis, and manufacturing. With nearly three decades of industry experience, the firm provides a comprehensive suite of services that bridge the gap between conceptual design and market-ready solutions. Their dual-facility infrastructure in Blue Springs and Pleasant Hill serves as a hub for rigorous R&D, quality control, and essential EPA/FDA regulatory studies. By maintaining a focus on cost-effective manufacturing and technical precision, Ecto Development has established itself as a preferred partner for major industry players seeking to navigate the complexities of animal health product commercialization.
How much funding has Ecto Development raised?
Ecto Development has raised a total of $134K across 1 funding round:
Debt
$134K
Debt (2021): $134K with participation from PPP
Key Investors in Ecto Development
PPP
Public-Private Partnership
What's next for Ecto Development?
With the recent infusion of capital, Ecto Development is poised to scale its laboratory capabilities and deepen its regulatory expertise. The company's strategic roadmap likely involves enhancing its capacity for large-scale manufacturing while maintaining the high-touch, client-centric model that has defined its 29-year history. As the animal health market continues to demand more sophisticated chemical analysis and faster time-to-market for new therapeutics, Ecto Development is strategically aligned to capitalize on these industry shifts. Future growth will likely center on optimizing operational efficiencies and potentially expanding its portfolio of FDA-compliant service offerings to meet the evolving needs of global veterinary health partners.
See full Ecto Development company page
